ESTRO Teaching course and workshop: Current clinical issues in breast cancer
|
 |
P. Poortmans (The Netherlands)
|
Making the case for standardising and guidelines |
|
L. Boersma (The Netherlands)
|
The breast, thoracic wall and boost |
|
A. Biete Sola (Spain)
|
The history of post-mastectomy radiotherapy: back to the future? |
|
S. Darby (United Kingdom)
|
Lessons from meta-analyses of clinical trials |
|
B. Cutuli (France)
|
Indications and target volumes for post-mastectomy radiotherapy |
|
I. Kunkler (United Kingdom)
|
Local control versus survival: what about toxicity? |
European Group for Breast Cancer Screening: Current issues in breast screening
|
|
H.J. de Koning (The Netherlands)
|
Evidence for screening older women? |
|
P. Skaane (Norway)
|
What new evidence on digital mammography and screening? |
|
F. Thibault (France)
|
Overview on current data on digital tomosynthesis imaging |
|
P. Taylor (United Kingdom)
|
Critical appraisal of computer aided detection (CAD) |
|
C. de Wolf (Switzerland)
|
Making digital mammography work for screening |
European Society of Surgical Oncology: The future of sentinel lymph node biopsy
|
|
E.J.T. Rutgers (The Netherlands)
|
Sentinel node biopsy - State of the art |
|
R. Valdes-Olmos (The Netherlands)
|
Sentinel lymph node today - State of the art & new nuclear medecine tools |
|
S. Bianchi (Italy)
|
Frozen sections - Yes or No |
|
G. Viale (Italy)
|
Prognostic implications of minimal lymph node involvement |
|
P.J. Van Diest (The Netherlands)
|
Clinical relevance of sentinel node metastases |
|
O. Gentilini (Italy)
|
SNB after breast surgery and in muticentric disease |
|
V. Galimberti (Italy)
|
SNB during pregnancy and SNB in male breast cancer |
|
P. Veronesi (Italy)
|
SNB in DCIS |
|
C.J.H. van de Velde (The Netherlands)
|
Why before and not after? |
|
J. Pierga (France)
|
What a medical oncologist thinks about sentinel node biopsy before, after and before and after (if possible) neo-adjuvant chemotherapy |
|
A.L. Vahrmeijer (The Netherlands)
|
Image guided surgery on sentinel node |
|
G. Viale (Italy)
|
Expert using gene search breast lymph node assay |
International Breast Ultrasound School: Breast Ultrasound - Update
|
|
H. Madjar (Germany)
|
Update of imaging indications and US-BI-RADS |
|
E. Durante (Italy)
|
Evolving role of intraoperative imaging |
|
R. Wilson (United Kingdom)
|
Update and new developments in breast interventions |
Flims Alumni Club: Controversies in the adjuvant treatment of breast cancer
|
|
G. Vlastos (Switzerland)
|
Micrometastases in SLN: Do they matter with respect to adjuvant therapy? |
|
C. Sotiriou (Belgium)
|
Treatment decisions based on genomic profile vs traditional prognostic facors: advantages, disadvantages |
|
G. Atalay Basaran (Turkey)
|
Taxanes as adjuvant therapy of breast cancer |
|
S. Braga (Portugal)
|
Are all aromatase inhibitors created equal? |
|
F. Cardoso (Belgium)
|
Adjuvant trastuzumab - For all Her-2 + patients? How long? |
SenoNetwork meeting: Breast units: The need for a structured network
|
|
M. Menke-Pluymers (The Netherlands)
|
Improving quality in breast cancer care - the Dutch experience |
|
M. Gnant (Austria)
|
Adjuvant MUC- 1Vaccination trial |
|
L. Fallowfield (United Kingdom)
|
Psychological support |
|
C. Wells (United Kingdom)
|
EQA schemes in breast pathology |
|
C. Rageth (Switzerland)
|
Multidisciplinary meeting |
|
M. Rosselli del Turco (Italy)
|
Quality indicators |
|
A. Ponti (Italy)
|
Data monitoring |
Opening session: Opening session
|
|
J.R. Yarnold (United Kingdom)
|
Research progress and priorities in breast radiotherapy |
Keynote symposium: Partnership for the fight against breast cancer
|
|
C. Murphy-Whyte (Ireland)
|
Specialist Breast Units – The patient advocate perspective |
|
L. Cataliotti (Italy)
|
EUSOMA – Achieving the critical practice |
|
V. Mazeau Woynar (France)
|
Practice recommendations of the French National Institute of Cancer for the management of patients with breast cancer |
|
L.J. van 't Veer (The Netherlands)
|
Partnership in translational research - speaking each other's language |
|
R.E. Coleman (United Kingdom)
|
Partnership approach to clinical research in the UK |